APA (7th ed.) Citation

Burgel, P., Sermet-Gaudelus, I., Durieu, I., Kanaan, R., Macey, J., Grenet, D., . . . Pouradier, D. (2023). The French compassionate programme of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with advanced lung disease and no F508del CFTR variant. The European respiratory journal, 61(5), . https://doi.org/10.1183/13993003.02437-2022

Chicago Style (17th ed.) Citation

Burgel, Pierre-Régis, et al. "The French Compassionate Programme of Elexacaftor/tezacaftor/ivacaftor in People with Cystic Fibrosis with Advanced Lung Disease and No F508del CFTR Variant." The European Respiratory Journal 61, no. 5 (2023). https://doi.org/10.1183/13993003.02437-2022.

MLA (9th ed.) Citation

Burgel, Pierre-Régis, et al. "The French Compassionate Programme of Elexacaftor/tezacaftor/ivacaftor in People with Cystic Fibrosis with Advanced Lung Disease and No F508del CFTR Variant." The European Respiratory Journal, vol. 61, no. 5, 2023, https://doi.org/10.1183/13993003.02437-2022.